Page last updated: 2024-11-03

propafenone and Psoriasis

propafenone has been researched along with Psoriasis in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capella, GL1
Palleschi, GM1
Bellandi, S1
Torchia, D1

Other Studies

2 other studies available for propafenone and Psoriasis

ArticleYear
[Psoriasis worsened by propafenone].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:4

    Topics: Aged; Anti-Arrhythmia Agents; Humans; Male; Propafenone; Psoriasis; Severity of Illness Index; Tachy

2005
Propafenone-induced psoriasis.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:2

    Topics: Aged; Anti-Arrhythmia Agents; Female; Humans; Propafenone; Psoriasis; Treatment Outcome

2008